Vir Biotechnology Inc <VIR.O>: Morgan Stanley Cuts Target Price to $25.00 From $27.00
VIR•Related News
Fox Q4 Revenue USD 4,210 Million Vs. IBES Estimate USD 3,643 Million
FOXA•
Praxis Precision net loss widens 17.7% to $83.72 million in Q2 FY26
PRAX•
vTv Therapeutics Q2 FY26 net loss widens to $13.1 million; R&D expenses more than doubled to $8.8 million
VTVT•
Lemaitre Vascular, Inc. <LMAT.O>: Barrington Research Raises to Outperform From Market Perform
LMAT•
Shopify Inc. <SHOP.TO>: ATB Cormark Capital Markets raises target price to C$260 from C$240
SHOP•